Actively Recruiting
18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma
Led by First Affiliated Hospital of Zhejiang University · Updated on 2025-08-07
80
Participants Needed
2
Research Sites
187 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to evaluate the diagnostic performance and tumor burden of 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with pheochromocytoma.
CONDITIONS
Official Title
18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 30 to 80 years old, primary school education or above, with a regular caregiver
- Clinically diagnosed with pheochromocytoma
- Able to provide informed consent and understand and comply with study requirements
You will not qualify if you...
- Serious primary diseases such as heart, brain, liver, kidney, or blood system disorders
- Uncontrolled hypertension or high-risk blood pressure (systolic > 180 mmHg or diastolic > 110 mmHg)
- Mental disorders or primary affective disorders
- Unable to understand or follow the study protocol or provide informed consent
- Contraindications to PET imaging, including pregnancy, breastfeeding, or recent plans for childbirth
- Allergy to imaging agents
- Inability to cooperate with PET scanning due to conditions like hypoglycemia, severe pain, or tremor
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310003
Actively Recruiting
2
The First Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310006
Actively Recruiting
Research Team
P
Peipei Wang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here